Our resource hub is home to a wealth of articles, stories and videos about managing and living with type 1 diabetes.
Place your order for our free information packs that support adults and children who have been recently diagnosed.
Our researchers are working on different ways to develop a cure for type 1 diabetes - from growing insulin-producing beta cells in labs to hacking the immune system.
Learn about the technologies that can deliver insulin automatically when needed. And discover the next generation of insulins that are currently being developed.
You could win a cash prize of up to £25,000 when you play the Breakthrough T1D lottery. As well as the chance to win great prizes, you’ll also help fund our research to find a cure for type 1 diabetes.
Our volunteers generously give us their time, skills and experience to tell people about our work, and to help us raise vital funds for research into better treatments and ultimately a cure for T1D.
Our ambitious new roadmap is aimed at driving significant advancements in type 1 diabetes research, treatment, and care.
Your donation helps support people living with type 1 diabetes and funds the best treatment and cure research.
We provide a wealth of information and free resources to help you support and empower your patients or students.
Take our free course for schools to learn more about supporting pupils with type 1 diabetes in educational settings.
Home > News & events > News > New report identifies ‘disconnect’ in specialist diabetes care for adults with mental health problems
A new report has revealed a critical disconnect between mental health services and specialist diabetes teams, leaving adults who self‑administer insulin without the coordinated support they need. The report calls for urgent action to close these gaps and protect vulnerable people from avoidable harm.
The report, published by the Health Services Safety Investigations Body (HSSIB) examined patients under the care of community mental health services. They identified incidents where people have intentionally not taken their insulin as prescribed, including where people had Type 1 Diabetes and Disordered Eating (T1DE).
HSSIB heard experiences from patients, families, carers, and staff across primary care, mental health and diabetes services. The report shines a light on the disconnect between the services with key findings including:
The report also sets out a key finding around type 1 diabetes and disordered eating (T1DE). HSSIB identified that whilst it contributes to significant patient harm, they heard varying views about what T1DE is and research gaps around the identification and care for patients with T1DE.
The harm that can be caused by the safety issues identified are highlighted in more detail in two powerful cases set out the report. Alex and Megan’s experiences were shared by their families as sadly both had died. Alex following self-administration of insulin and Megan after experiencing type 1 diabetes and disordered eating. Both Alex and Megan experienced difficulties accessing the specialist mental health and diabetes care they needed.
Alex’s family described how there were no services available that met her needs with no collaborative care planning. They further described a lack of support for someone experiencing an emotionally unstable personality disorder. Megan’s family told HSSIB that she never received a formal diagnosis of T1DE. They described the lack of accepted definition of the condition and an absence of pathways of care. Her family described “siloed treatment models and no joint working between specialist mental and physical health services.”
From a staff perspective, a patient experiencing a mental health problem with access to insulin was described as a ‘huge red flag’. Several staff had known patients who had died following self-harm with insulin. They told the investigation they were ‘scared’ and often ‘helpless to do anything’. Community mental health teams also described how they had experienced psychological harm and distress following incidents.
HSSIB’s findings and subsequent recommendations are designed to strengthen care for people with co-existing mental health conditions and insulin-treated diabetes, with a clear focus on improving integration between services and advancing recognition and research into T1DE.
Nick Woodier, Senior Safety Investigator at HSSIB, said: “Our report emphasises that too often individuals managing both diabetes and a mental health problem face a troubling disconnect between specialist physical and mental health services. This fragmentation of care can leave patients without the co-ordinated support they need, increasing the risk of harm. Alex and Megan’s cases demonstrate that these are not just abstract safety concerns documented in reports; they have a real and devastating impact on people and their families.”
Hilary Nathan, Director of Policy at Breakthrough T1D said “Type 1 Disordered Eating, or T1DE, is a serious and life threatening condition. The people who live with it deserve compassion, understanding and consistent, coordinated care. Yet this report reveals a deeply troubling reality. Healthcare services are failing to provide even the most basic safeguard for those managing both a mental health condition and type 1 diabetes – the safe administration of insulin. The consequences of this failure are devastating and, in some cases, fatal. These findings cannot be ignored. Healthcare professionals, policymakers and all those with responsibility for patient safety must listen with urgency and act decisively. Without immediate and meaningful change, more lives will be placed at risk.”
If you or someone you know is living with type 1 diabetes and experiencing disordered eating, we have information, shared experiences and links to further support.
Dealing with type 1 every day can have an emotional impact, whether you’re newly diagnosed or have been living with type 1 for some time.
Find out about our work to make T1D treatments available to everyone who needs or wants them.
Find out about our research to find cures for T1D and make everyday life better for those who face it.
Highlights from an extraordinary year in type 1 diabetes (T1D) research, treatment, advocacy and policy.
We’re aware of growing concern around insulin supply in the UK, and we want to reassure our community that this is not a general insulin shortage. There is no need to change the type of insulin you use.
If you use the Dexcom G6 app on your Android smartphone, the newest Android 16 operating system may disrupt how the app functions.
We're calling for urgent reform as new report reveals older people with T1D are systematically failed by health and social care services.
Immunotherapy, beta cell replacement, smart insulins – we’re driving research in the most promising areas to find cures and better treatments for type 1 diabetes.